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Introduction
GSDII (Pompe disease) is a rare, autosomal recessive
disease due to alpha-glucosidase (GAA) deficiency that
presents with infantile and late-onset forms. Herein, we
describe a cohort of 29 late-onset patients (15 males
and 14 females, aged 9 to 76), and discuss some unusual
clinical features seen in 4 of them.
Methods
Clinical evaluations were performed in all patients using
the Walton and Gardner-Medwin, MRC and GSGC
scales, and the 6MWT. Respiratory function was
assessed using FVC% in upright and supine positions.
All patients underwent morphological and biochemical
examinations, muscle MRI, neurophysiological studies,
and molecular genetic analysis.
Results
Out of 29 patients, 15 received enzyme replacement
therapy (ERT). 57% initially had limb-girdle involve-
ment, 29% an isolated hyperCKemia, and 14% respira-
tory insufficiency. Neurophysiological studies revealed a
myopathic pattern in 48% of patients, neurogenic or
mixed in 28%, whereas 24% of patients did not show
any electrical abnormality. In the examined patients,
muscle MRI showed early involvement of ileopsoas, glu-
teus and posterior thigh muscles. Morphological studies
revealed vacuolar myopathy in 68% of patients, and bio-
chemical analysis showed residual alpha-glucosidase
activity ranging from 0.01% to 25%. Molecular genetic
analysis confirmed IVS13T>G as the most common
mutation, but we also identified three novel point muta-
tions. Atypical clinical features were observed in 4 out
of 29 patients: a 66-year-old female with disease onset
involving distal upper limbs muscles; a 70-year-old male
with mesial temporal sclerosis without epileptic or cog-
nitive disorders; a 46-year-old male with severe neuro-
sensory hearing loss (with very early hearing difficulties);
and a 51-year-old female with a congenital absence of a
thyroid lobe.
Conclusion
Our study confirms the clinical, morphological and mole-
cular genetic heterogeneity of late-onset GSDII. Muscle
MRI is a very useful tool for muscle damage evaluation,
especially at the early stages of the disease. Based on our
experience with some atypical cases, we suggest always
performing a complete clinical and laboratory evaluation
of patients in order to highlight unusual muscular (e.g.
distal involvement) and/or CNS presentations. These
cases reinforce the hypothesis that modifier genes and/or
epigenetic factors may contribute to clinical presenta-
tions of Pompe disease.
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